- Home
- SUPV vs OPK Comparison
SUPV vs OPK Comparison
Compare SUPV & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPV
- OPK
- Stock Information
- Founded
- SUPV 1887
- OPK 2007
- Country
- SUPV Argentina
- OPK United States
- Employees
- SUPV N/A
- OPK N/A
- Industry
- SUPV Commercial Banks
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- SUPV Finance
- OPK Health Care
- Exchange
- SUPV Nasdaq
- OPK Nasdaq
- Market Cap
- SUPV 908.5M
- OPK 1.0B
- IPO Year
- SUPV 2016
- OPK 1995
- Fundamental
- Price
- SUPV $10.62
- OPK $1.64
- Analyst Decision
- SUPV
- OPK Strong Buy
- Analyst Count
- SUPV 0
- OPK 3
- Target Price
- SUPV N/A
- OPK $2.75
- AVG Volume (30 Days)
- SUPV 1.2M
- OPK 4.1M
- Earning Date
- SUPV 11-25-2024
- OPK 11-07-2024
- Dividend Yield
- SUPV 1.60%
- OPK N/A
- EPS Growth
- SUPV 514.29
- OPK N/A
- EPS
- SUPV 0.24
- OPK N/A
- Revenue
- SUPV $582,756,903.00
- OPK $711,408,000.00
- Revenue This Year
- SUPV N/A
- OPK N/A
- Revenue Next Year
- SUPV N/A
- OPK $0.50
- P/E Ratio
- SUPV $9.77
- OPK N/A
- Revenue Growth
- SUPV N/A
- OPK N/A
- 52 Week Low
- SUPV $1.94
- OPK $0.85
- 52 Week High
- SUPV $10.76
- OPK $1.75
- Technical
- Relative Strength Index (RSI)
- SUPV 78.67
- OPK 64.63
- Support Level
- SUPV $9.40
- OPK $1.37
- Resistance Level
- SUPV $10.04
- OPK $1.71
- Average True Range (ATR)
- SUPV 0.48
- OPK 0.09
- MACD
- SUPV 0.12
- OPK 0.02
- Stochastic Oscillator
- SUPV 93.52
- OPK 79.41
About SUPV Grupo Supervielle S.A. each Representing five Class B shares
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, Asset Management, and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.